Are you searching for the best growth stocks for 2026? The Ranks 11-20 Improvers portfolio offers a dynamic investment strategy focused on identifying undervalued stocks with high potential for appreciation. Designed as a sector ETF alternative, this portfolio targets companies showing significant improvement in performance rankings, aiming for capital growth over the long term. With a Tradestie Score of 60.07/100 and a Diversification Score of 74.3/100, it balances risk and reward through a concentrated yet strategic selection of just five holdings, heavily weighted toward healthcare stocks and financial services.
The stock selection in this portfolio is led by powerhouse names like Amgen Inc. (AMGN), commanding a 33.6% allocation in the healthcare sector. Amgen (AMGN) stands out with its innovative biotech pipeline, making it one of the top healthcare stocks to buy for Q1 2026 based on current valuations and growth forecasts. Financial services are represented by Blue Acquisition Corp. (BACC) at 28.9% and Agriculture & Natural Solutions Acquisition Corporation (ANSC) with a combined 37.5% allocation. These financial services stocks are attractive due to their potential for mergers and acquisitions, positioning them as undervalued stocks with upside in the 2026 market outlook. Their focus on niche markets adds a layer of resilience amid economic shifts. Together, these picks target sectors poised for growth, with healthcare at 54% and financial services at 46% of the portfolio.
This portfolio suits aggressive growth investors and those building a retirement portfolio with a long-term horizon. However, beginner investors should note the medium risk level due to sector concentration and market volatility. Key considerations include healthcare policy changes and financial sector regulatory risks, which could impact returns. If you’re a passive income seeker or growth-focused investor, explore this strategy for exposure to the best growth stocks in 2026.